NEULANDLAB

NEULANDLAB

Pharmaceuticals & Drugs

1448.05

0.00 (0.00%)

stock change
Market Cap1,941 CrEPS64.5High1524.85
Stock P/E23.5Net Profit Margin13.1Low1425
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
explain

Neuland Labs Price chart

explain

NSE: Neuland Labs

explain

Performance

Today’s Low

Today’s High

1425

1524.85

52W Low

52W High

967

2002

Open Price1518Volume99
Prev. Close1516.85
explain

Fundamentals

explain
Market Cap1,941 CrROE7.9%
P/E Ratio(TTM)23.5EPS(TTM)50.7
P/B Ratio2.2Dividend Yield0.3%
Industry P/E65.7Book Value683.0
Face Value10.0
explain

About the Company

Named after Father Nieuwland of Notre dame, Neuland Laboratories was incorporated in 1984 by Dr. D. R. Rao for the manufacture of Salbutamol Sulphate, with mere 40 employees.

It has started its commercial production of Salbutamol Sulphate in the year 1986. It has since grown to become one of the most reliable API source for Pharma Industry with addition of more products in course of years.

Today the company with a total employee strength of 1000+ is the preferred supplier of APIs with unmatched quality and timely delivery. Neuland is a quality conscious, research driven, reliable source of active pharmaceutical ingredients.

Operating from India for over two decades, Neuland is the preferred source for the Pharmaceutical Industry across the globe, with strengths in Research based Chemistry and Manufacturing.

The Company has started its commercial production of Salbutamol Sulphate in the year 1986. It has since grown to become one of the most reliable API source for Pharma Industry with addition of more products in course of years.Today the company with a total employee strength of 1000+ is the preferred supplier of APIs with unmatched quality and timely delivery.

Neuland has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions. Safety aspects have been given utmost significance may it be plant installation, equipment, systems and personnel to ensure smooth productivity. Dedicated team of manufacturing with incorporation of latest production techniques guarantees delivery of latest intermediate and product to our customers across the globe.

Product range of the company includes:

  • Anti -Asthmatics
  • Fluoroquinolones
  • Cardiovascular
  • CNS
  • Corticosteroids
  • Anti-Ulcerant
  • Anti-Fungal
  • Anti-Parkinsons
  • Anti-Alzheimers

Achievements/ recognition:

  • Received a string of regulatory approvals from USFDA & EDQM for its major products (e.g., Ciprofloxacin HCl, Salbutamol Sulphate) USFDA systems inspection for its pashamylaram Facility (Unit-II) in the year 1999
  • USFDA systems inspection for its Bonthapally (Unit-I) bringing both facilities under full cGMP compliance in 2004
  • Received cGMP clearance for both facilities from TGA, Australia in 2004.
  • Certificate of suitability for product itraconazole in 2006.
Parent OrganisationNeuland Laboratories Ltd.Managing DirectorDavuluri Saharsh Rao
Founded1984NSE SymbolNEULANDLAB
explain

Financials

All values are in Rs Cr

explain

Shareholding Pattern

explain

Peer Comparison

Company52 WeekMarket PriceP/E RatioFinancialsShare Holding
explain

Recently Viewed

No Recently Viewed Stocks
explain

Frequently asked questions

You can buy the shares of Neuland Labs using the Trinkerr Website or by downloading the Trinkerr app from Android and Apptore.